Each N-PORT filing of IHE compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.https://themulden.com/enhttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/57 positions became 58: 3 added (0.8% of the fund), 2 dropped (1.32%). Turnover proxy 6.6%. Largest increases: ELI LILLY AND COMPANY 21.06% to 22.25%; Definium Therapeutics Inc 0.52% to 1.39%; CORCEPT THERAPEUTICS INCORPORATED 1.05% to 1.9%; Liquidia Corp 0.72% to 1.28%; AXSOME THERAPEUTICS, INC. 2% to 2.42%; ORGANON & CO. 0.44% to 0.81%. Largest decreases: ZOETIS INC. 4.52% to 3.73%; PFIZER INC. 4.71% to 3.97%; JOHNSON & JOHNSON 23.03% to 22.44%; ELANCO ANIMAL HEALTH INCORPORATED 3.32% to 2.81%; ROYALTY PHARMA PLC 4.7% to 4.34%; PRESTIGE CONSUMER HEALTHCARE INC. 0.78% to 0.51%. New: Veradermics Inc (0.56%), AtaiBeckley Inc (0.23%), XAV HEALTH CARE SEP26 (0%). Gone: Terns Pharmaceuticals Inc (1.27%), LENZ Therapeutics Inc (0.06%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 24 Aug 2026 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/56 positions became 57: 5 added (2.4% of the fund), 4 dropped (2.3%). Turnover proxy 7.6%. Largest increases: JOHNSON & JOHNSON 22.01% to 23.03%; ROYALTY PHARMA PLC 3.94% to 4.7%; PFIZER INC. 4.24% to 4.71%; VIATRIS INC. 3.89% to 4.35%; JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 2.8% to 3.21%; NEKTAR THERAPEUTICS 0.23% to 0.56%. Largest decreases: ELI LILLY AND COMPANY 23.76% to 21.06%; WAVE Life Sciences Ltd 0.67% to 0.29%; Nuvation Bio Inc 0.58% to 0.29%; ZOETIS INC. 4.68% to 4.52%; Crinetics Pharmaceuticals Inc 1.2% to 1.04%; OCULAR THERAPEUTIX, INC. 0.56% to 0.41%. New: INDIVIOR PHARMACEUTICALS, INC. (1.06%), Definium Therapeutics Inc (0.52%), Alumis Inc (0.5%), LB Pharmaceuticals Inc (0.17%), BIOAGE Labs Inc (0.15%). Gone: INDIVIOR PLC (1.21%), AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY (0.57%), Mind Medicine (MindMed) Inc (0.36%), Ventyx Biosciences Inc (0.16%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 22 May 2026 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/45 positions became 56: 12 added (4.83% of the fund), 1 dropped (0%). Turnover proxy 8.6%. Largest increases: ELI LILLY AND COMPANY 22.2% to 23.76%; BRISTOL-MYERS SQUIBB COMPANY 4.2% to 4.63%; ZOETIS INC. 4.3% to 4.68%; MERCK & CO., INC. 4.39% to 4.74%; WAVE Life Sciences Ltd 0.33% to 0.67%; Nuvation Bio Inc 0.33% to 0.58%. Largest decreases: CORCEPT THERAPEUTICS INCORPORATED 2.87% to 0.88%; JOHNSON & JOHNSON 23.16% to 22.01%; ELANCO ANIMAL HEALTH INCORPORATED 3.68% to 3.05%; PERRIGO COMPANY PUBLIC LIMITED COMPANY 1.13% to 0.52%; ORGANON & CO. 1.02% to 0.51%; VIATRIS INC. 4.24% to 3.89%. New: INDIVIOR PLC (1.21%), Terns Pharmaceuticals Inc (0.94%), EYEPOINT, INC. (0.38%), XERIS BIOPHARMA HOLDINGS, INC. (0.35%), Trevi Therapeutics Inc (0.35%), OMEROS CORPORATION (0.33%). Gone: XAV HEALTH CARE DEC25 (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 23 Feb 2026 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/38 positions became 45: 8 added (3.63% of the fund), 1 dropped (0%). Turnover proxy 5.2%. Largest increases: JOHNSON & JOHNSON 22.65% to 23.16%; Liquidia Corp 0.3% to 0.57%; LIGAND PHARMACEUTICALS INCORPORATED 1.1% to 1.28%; ELANCO ANIMAL HEALTH INCORPORATED 3.57% to 3.68%; Mind Medicine (MindMed) Inc 0.22% to 0.33%; HARROW, INC. 0.48% to 0.58%. Largest decreases: PRESTIGE CONSUMER HEALTHCARE INC. 1.98% to 1.13%; PERRIGO COMPANY PUBLIC LIMITED COMPANY 1.85% to 1.13%; CORCEPT THERAPEUTICS INCORPORATED 3.48% to 2.87%; ROYALTY PHARMA PLC 4.87% to 4.28%; JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 3.29% to 2.94%; VIATRIS INC. 4.58% to 4.24%. New: Crinetics Pharmaceuticals Inc (1.44%), AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY (0.55%), Amylyx Pharmaceuticals Inc (0.41%), NEKTAR THERAPEUTICS (0.4%), LENZ Therapeutics Inc (0.34%), PHIBRO ANIMAL HEALTH CORPORATION (0.3%). Gone: XAV HEALTH CARE SEP25 (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 25 Nov 2025 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/39 positions became 38: 1 added (0% of the fund), 2 dropped (4.63%). Turnover proxy 6.3%. Largest increases: ELANCO ANIMAL HEALTH INCORPORATED 2.11% to 3.57%; ROYALTY PHARMA PLC 4.18% to 4.87%; VIATRIS INC. 4.16% to 4.58%; LIGAND PHARMACEUTICALS INCORPORATED 0.81% to 1.1%; PERRIGO COMPANY PUBLIC LIMITED COMPANY 1.55% to 1.85%; MERCK & CO., INC. 4.24% to 4.54%. Largest decreases: CORCEPT THERAPEUTICS INCORPORATED 4.32% to 3.48%; ORGANON & CO. 1.56% to 1.27%; BRISTOL-MYERS SQUIBB CO 4.5% to 4.25%; ZOETIS INC. 4.49% to 4.32%; Edgewise Therapeutics Inc 0.52% to 0.46%; BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agen 0.12% to 0.08%. New: XAV HEALTH CARE SEP25 (0%). Gone: Intra-Cellular Therapies Inc (4.43%), OMEROS CORPORATION (0.19%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 26 Aug 2025 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/43 positions became 39: 0 added (0% of the fund), 4 dropped (0.84%). Turnover proxy 6.4%. Largest increases: CORCEPT THERAPEUTICS INCORPORATED 1.78% to 4.32%; Intra-Cellular Therapies Inc 3.11% to 4.43%; AXSOME THERAPEUTICS, INC. 1.3% to 1.93%; ROYALTY PHARMA PLC 3.68% to 4.18%; PRESTIGE CONSUMER HEALTHCARE INC. 1.46% to 1.73%; JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 2.81% to 3.04%. Largest decreases: JOHNSON & JOHNSON 23.75% to 22.47%; ELI LILLY AND COMPANY 23.35% to 22.17%; PFIZER INC. 5.06% to 4.35%; MERCK & CO., INC. 4.8% to 4.24%; VIATRIS INC. 4.7% to 4.16%; BRISTOL-MYERS SQUIBB CO 4.81% to 4.5%. Gone: Neumora Therapeutics Inc (0.34%), Pliant Therapeutics Inc (0.27%), PHATHOM PHARMACEUTICALS, INC. (0.14%), REVANCE THERAPEUTICS, INC. (0.1%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 23 May 2025 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/39 positions became 43: 6 added (1.98% of the fund), 2 dropped (4.81%). Turnover proxy 7.8%. Largest increases: ELI LILLY AND COMPANY 21.61% to 23.35%; JOHNSON & JOHNSON 22.09% to 23.75%; PFIZER INC. 4.38% to 5.06%; MERCK & CO., INC. 4.45% to 4.8%; Intra-Cellular Therapies Inc 2.81% to 3.11%; Tarsus Pharmaceuticals Inc 0.45% to 0.73%. Largest decreases: ROYALTY PHARMA PLC 4.29% to 3.68%; ELANCO ANIMAL HEALTH INCORPORATED 2.84% to 2.26%; ORGANON & CO. 1.93% to 1.45%; AMPHASTAR PHARMACEUTICALS INC 0.72% to 0.53%; ZOETIS INC. 4.62% to 4.43%; Arvinas Inc 0.61% to 0.46%. New: WAVE Life Sciences Ltd (0.55%), OCULAR THERAPEUTIX, INC. (0.41%), HARROW, INC. (0.39%), OMEROS CORPORATION (0.22%), Liquidia Corp (0.21%), Evolus Inc (0.21%). Gone: CATALENT, INC. (4.29%), CASSAVA SCIENCES, INC. (0.52%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 24 Feb 2025 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/38 positions became 39: 2 added (0.68% of the fund), 1 dropped (0%). Turnover proxy 3.7%. Largest increases: CORCEPT THERAPEUTICS INCORPORATED 1.22% to 1.68%; BRISTOL-MYERS SQUIBB COMPANY 4.42% to 4.78%; CASSAVA SCIENCES, INC. 0.23% to 0.52%; AMNEAL PHARMACEUTICALS, INC. 0.3% to 0.48%; ZOETIS INC. 4.45% to 4.62%; MERCK & CO., INC. 4.29% to 4.45%. Largest decreases: ELI LILLY AND COMPANY 23.55% to 21.61%; JOHNSON & JOHNSON 22.68% to 22.09%; PACIRA BIOSCIENCES, INC. 0.55% to 0.27%; ORGANON & CO. 2.18% to 1.93%; PFIZER INC. 4.56% to 4.38%; Arvinas Inc 0.75% to 0.61%. New: Neumora Therapeutics Inc (0.43%), PHATHOM PHARMACEUTICALS, INC. (0.25%). Gone: XAV HEALTH CARE SEP24 (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 26 Nov 2024 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/36 positions became 38: 4 added (0.62% of the fund), 2 dropped (0.07%). Turnover proxy 4.1%. Largest increases: ELI LILLY AND COMPANY 22.35% to 23.55%; JOHNSON & JOHNSON 22.24% to 22.68%; CORCEPT THERAPEUTICS INCORPORATED 0.9% to 1.22%; Intra-Cellular Therapies Inc 2.44% to 2.76%; ZOETIS INC. 4.13% to 4.45%; ORGANON & CO. 1.89% to 2.18%. Largest decreases: BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agen 1.43% to 0.05%; MERCK & CO., INC. 4.78% to 4.29%; ROYALTY PHARMA PLC 4.57% to 4.19%; Arvinas Inc 1.1% to 0.75%; PERRIGO COMPANY PUBLIC LIMITED COMPANY 1.72% to 1.43%; ELANCO ANIMAL HEALTH INCORPORATED 3.16% to 2.92%. New: Enliven Therapeutics Inc (0.24%), Nuvation Bio Inc (0.19%), Mind Medicine (MindMed) Inc (0.19%), XAV HEALTH CARE SEP24 (0%). Gone: Amylyx Pharmaceuticals Inc (0.05%), XAV HEALTH CARE JUN24 (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 26 Aug 2024 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/34 positions became 36: 4 added (1.13% of the fund), 2 dropped (1.18%). Turnover proxy 6%. Largest increases: BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agen 0.12% to 1.43%; ELI LILLY AND COMPANY 21.25% to 22.35%; JOHNSON & JOHNSON 21.5% to 22.24%; ROYALTY PHARMA PLC 4.2% to 4.57%; MERCK & CO., INC. 4.44% to 4.78%; PFIZER INC. 4.29% to 4.57%. Largest decreases: JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 3.59% to 2.98%; Intra-Cellular Therapies Inc 2.97% to 2.44%; ZOETIS INC. 4.66% to 4.13%; CORCEPT THERAPEUTICS INCORPORATED 1.36% to 0.9%; AMPHASTAR PHARMACEUTICALS INC 1.07% to 0.65%; VIATRIS INC. 4.8% to 4.38%. New: Edgewise Therapeutics Inc (0.46%), Tarsus Pharmaceuticals Inc (0.38%), AMNEAL PHARMACEUTICALS, INC. (0.27%), XAV HEALTH CARE JUN24 (0.02%). Gone: CymaBay Therapeutics Inc (1.18%), XAV HEALTH CARE MAR24 (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 24 May 2024 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/35 positions became 34: 3 added (1.57% of the fund), 4 dropped (1.07%). Turnover proxy 6.9%. Largest increases: ELANCO ANIMAL HEALTH INCORPORATED 2.37% to 3.4%; Intra-Cellular Therapies Inc 1.99% to 2.97%; Arvinas Inc 0.45% to 1.05%; AMPHASTAR PHARMACEUTICALS INC 0.75% to 1.07%; CORCEPT THERAPEUTICS INCORPORATED 1.05% to 1.36%; AXSOME THERAPEUTICS, INC. 1.16% to 1.43%. Largest decreases: JOHNSON & JOHNSON 23.65% to 21.5%; ELI LILLY AND COMPANY 23.01% to 21.25%; BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agen 0.62% to 0.12%; PFIZER INC. 4.63% to 4.29%; ROYALTY PHARMA PLC 4.48% to 4.2%; BRISTOL-MYERS SQUIBB COMPANY 4.67% to 4.42%. New: CymaBay Therapeutics Inc (1.18%), ANI PHARMACEUTICALS, INC. (0.39%), XAV HEALTH CARE MAR24 (0%). Gone: Ventyx Biosciences Inc (0.7%), Aclaris Therapeutics Inc (0.16%), PHIBRO ANIMAL HEALTH CORPORATION (0.11%), Atea Pharmaceuticals Inc (0.1%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 23 Feb 2024 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/42 positions became 35: 1 added (0.64% of the fund), 8 dropped (5.14%). Turnover proxy 6.7%. Largest increases: JOHNSON & JOHNSON 22.86% to 23.65%; ELANCO ANIMAL HEALTH INCORPORATED 1.73% to 2.37%; CATALENT, INC. 2.9% to 3.51%; JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 2.94% to 3.5%; PFIZER INC. 4.13% to 4.63%; ROYALTY PHARMA PLC 3.98% to 4.48%. Largest decreases: ELI LILLY AND COMPANY 23.53% to 23.01%; REVANCE THERAPEUTICS, INC. 0.79% to 0.43%; ZOETIS INC. 4.61% to 4.47%; Intra-Cellular Therapies Inc 2.1% to 1.99%; CASSAVA SCIENCES, INC. 0.36% to 0.28%; PACIRA BIOSCIENCES, INC. 0.68% to 0.61%. New: SUPERNUS PHARMACEUTICALS, INC. (0.64%). Gone: AMICUS THERAPEUTICS, INC. (1.18%), MADRIGAL PHARMACEUTICALS, INC. (1.11%), REATA PHARMACEUTICALS, INC. (1.1%), Dice Therapeutics Inc (0.58%), IRONWOOD PHARMACEUTICALS, INC. (0.53%), CATALYST PHARMACEUTICALS, INC. (0.49%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 24 Nov 2023 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/43 positions became 42: 2 added (0.2% of the fund), 3 dropped (0.18%). Turnover proxy 20.4%. Largest increases: ELI LILLY AND COMPANY 4.95% to 23.53%; VIATRIS INC. 4.11% to 4.44%; AMPHASTAR PHARMACEUTICALS INC 0.55% to 0.8%; Intra-Cellular Therapies Inc 1.87% to 2.1%; Dice Therapeutics Inc 0.38% to 0.58%; ZOETIS INC. 4.45% to 4.61%. Largest decreases: MERCK & CO., INC. 19.53% to 4.65%; CATALENT, INC. 4.25% to 2.9%; ROYALTY PHARMA PLC 4.73% to 3.98%; JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 3.61% to 2.94%; PFIZER INC. 4.59% to 4.13%; ORGANON & CO. 2.35% to 1.97%. New: BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agen (0.2%), XAV HEALTH CARE SEP23 (0%). Gone: Nuvation Bio Inc (0.09%), Cara Therapeutics Inc (0.09%), XAV HEALTH CARE JUN23 (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 28 Aug 2023 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/44 positions became 43: 1 added (0% of the fund), 2 dropped (0.14%). Turnover proxy 18.7%. Largest increases: MERCK & CO., INC. 4.53% to 19.53%; CATALENT, INC. 3.39% to 4.25%; BRISTOL-MYERS SQUIBB COMPANY 4.05% to 4.64%; REATA PHARMACEUTICALS, INC. 0.44% to 1%; ROYALTY PHARMA PLC 4.22% to 4.73%; JOHNSON & JOHNSON 22.42% to 22.85%. Largest decreases: ELI LILLY AND COMPANY 18.65% to 4.95%; ELANCO ANIMAL HEALTH INCORPORATED 2.28% to 1.64%; ORGANON & CO. 2.97% to 2.35%; JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 4.2% to 3.61%; VIATRIS INC. 4.59% to 4.11%; MADRIGAL PHARMACEUTICALS, INC. 1.47% to 1.16%. New: XAV HEALTH CARE JUN23 (0%). Gone: BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agen (0.14%), XAV HEALTH CARE MAR23 (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 24 May 2023 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/43 positions became 44: 5 added (1.61% of the fund), 4 dropped (2.13%). Turnover proxy 20.5%. Largest increases: ELI LILLY AND COMPANY 4.9% to 18.65%; MADRIGAL PHARMACEUTICALS, INC. 0.33% to 1.47%; JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 3.49% to 4.2%; AXSOME THERAPEUTICS, INC. 0.59% to 1.11%; ORGANON & CO. 2.49% to 2.97%; VIATRIS INC. 4.14% to 4.59%. Largest decreases: PFIZER INC. 18.88% to 4.59%; JOHNSON & JOHNSON 23.52% to 22.42%; BRISTOL-MYERS SQUIBB COMPANY 4.89% to 4.05%; CATALENT, INC. 3.72% to 3.39%; REVANCE THERAPEUTICS, INC. 0.92% to 0.64%; PACIRA BIOSCIENCES, INC. 1.02% to 0.74%. New: LIGAND PHARMACEUTICALS INCORPORATED (0.45%), Dice Therapeutics Inc (0.44%), Ventyx Biosciences Inc (0.38%), Aclaris Therapeutics Inc (0.34%), XAV HEALTH CARE MAR23 (0%). Gone: ChemoCentryx Inc (1.36%), AERIE PHARMACEUTICALS, INC. (0.31%), CinCor Pharma Inc (0.26%), NGM Biopharmaceuticals Inc (0.2%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 24 Feb 2023 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/43 positions became 43: 3 added (0.93% of the fund), 3 dropped (0.27%). Turnover proxy 5.3%. Largest increases: ChemoCentryx Inc 0.46% to 1.36%; JOHNSON & JOHNSON 22.86% to 23.52%; REVANCE THERAPEUTICS, INC. 0.35% to 0.92%; BRISTOL-MYERS SQUIBB COMPANY 4.61% to 4.89%; CASSAVA SCIENCES, INC. 0.4% to 0.66%; CATALYST PHARMACEUTICALS, INC. 0.25% to 0.51%. Largest decreases: PFIZER INC. 20.38% to 18.88%; ELANCO ANIMAL HEALTH INCORPORATED 3.48% to 2.31%; ORGANON & CO. 3.2% to 2.49%; CATALENT, INC. 4.42% to 3.72%; ZOETIS INC. 4.58% to 4.37%; ROYALTY PHARMA PLC 4.63% to 4.45%. New: Amylyx Pharmaceuticals Inc (0.38%), Pliant Therapeutics Inc (0.29%), CinCor Pharma Inc (0.26%). Gone: Roivant Sciences Ltd (0.15%), Amneal Pharmaceuticals Inc (0.12%), Chicago Mercantile Exchange (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 28 Nov 2022 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/47 positions became 43: 0 added (0% of the fund), 4 dropped (0.6%). Turnover proxy 3.2%. Largest increases: Jazz Pharmaceuticals PLC 3.15% to 3.63%; Perrigo Co PLC 1.69% to 2.04%; Johnson & Johnson 22.52% to 22.86%; Zoetis Inc 4.28% to 4.58%; Organon & Co 2.91% to 3.2%; Royalty Pharma PLC 4.37% to 4.63%. Largest decreases: Elanco Animal Health Inc 4.06% to 3.48%; Catalent Inc 4.84% to 4.42%; Pfizer Inc 20.8% to 20.38%; Viatris Inc 4.33% to 4.03%; Arvinas Inc 0.96% to 0.69%; Pacira BioSciences Inc 1.12% to 0.99%. Gone: Antares Pharma Inc (0.23%), Endo International PLC (0.18%), Omeros Corp (0.12%), Phathom Pharmaceuticals Inc (0.07%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 25 Aug 2022 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/47 positions became 47: 1 added (0.16% of the fund), 1 dropped (0.26%). Turnover proxy 4.5%. Largest increases: Jazz Pharmaceuticals PLC 2.44% to 3.15%; Catalent Inc 4.24% to 4.84%; Johnson & Johnson 21.99% to 22.52%; Organon & Co 2.41% to 2.91%; Intra-Cellular Therapies Inc 1.21% to 1.71%; Pacira BioSciences Inc 0.84% to 1.12%. Largest decreases: Pfizer Inc 23.46% to 20.8%; Viatris Inc 4.6% to 4.33%; Zoetis Inc 4.49% to 4.28%; ChemoCentryx Inc 0.56% to 0.4%; Arvinas Inc 1.11% to 0.96%; Amicus Therapeutics Inc 0.9% to 0.78%. New: Roivant Sciences Ltd (0.16%). Gone: Zogenix Inc (0.26%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 26 May 2022 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/48 positions became 47: 3 added (0.82% of the fund), 4 dropped (0.51%). Turnover proxy 6.8%. Largest increases: Pfizer Inc 19.11% to 23.46%; Eli Lilly & Co 4.31% to 4.78%; ChemoCentryx Inc 0.3% to 0.56%; Bristol-Myers Squibb Co 4.33% to 4.57%; Intra-Cellular Therapies Inc 1% to 1.21%; Viatris Inc 4.43% to 4.6%. Largest decreases: Reata Pharmaceuticals Inc 0.99% to 0.23%; Perrigo Co PLC 2.29% to 1.62%; Organon & Co 3.01% to 2.41%; Atea Pharmaceuticals Inc 0.67% to 0.15%; Jazz Pharmaceuticals PLC 2.88% to 2.44%; Elanco Animal Health Inc 4.47% to 4.06%. New: Cassava Sciences Inc (0.51%), Harmony Biosciences Holdings Inc (0.3%), Chicago Mercantile Exchange (0.01%). Gone: Relmada Therapeutics Inc (0.15%), Spectrum Pharmaceuticals Inc (0.13%), Provention Bio Inc (0.12%), TherapeuticsMD Inc (0.11%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 25 Feb 2022 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/49 positions became 48: 0 added (0% of the fund), 1 dropped (0%). Turnover proxy 5.6%. Largest increases: Royalty Pharma PLC 1.39% to 4.44%; Pfizer Inc 18.04% to 19.11%; Atea Pharmaceuticals Inc 0.1% to 0.67%; Arvinas Inc 0.99% to 1.29%; Viatris Inc 4.17% to 4.43%; Nuvation Bio Inc 0.23% to 0.42%. Largest decreases: Jazz Pharmaceuticals PLC 4.2% to 2.88%; Reata Pharmaceuticals Inc 1.48% to 0.99%; Axsome Therapeutics Inc 0.71% to 0.35%; Zoetis Inc 4.76% to 4.41%; Bristol-Myers Squibb Co 4.61% to 4.33%; Eli Lilly & Co 4.58% to 4.31%. Gone: Chicago Mercantile Exchange (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 24 Nov 2021 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/47 positions became 49: 3 added (3.51% of the fund), 1 dropped (4.62%). Turnover proxy 8.3%. Largest increases: Jazz Pharmaceuticals PLC 3.47% to 4.2%; Elanco Animal Health Inc 4.03% to 4.62%; Eli Lilly & Co 4.07% to 4.58%; Pfizer Inc 17.54% to 18.04%; Reata Pharmaceuticals Inc 0.99% to 1.48%; Perrigo Co PLC 2.02% to 2.41%. Largest decreases: Merck & Co Inc 5.64% to 4.74%; ChemoCentryx Inc 0.96% to 0.26%; Johnson & Johnson 23.11% to 22.44%; Viatris Inc 4.45% to 4.17%; Endo International PLC 0.64% to 0.43%; Atea Pharmaceuticals Inc 0.29% to 0.1%. New: Organon & Co (3.01%), Antares Pharma Inc (0.27%), Nuvation Bio Inc (0.23%). Gone: Horizon Therapeutics Plc (4.62%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 26 Aug 2021 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/45 positions became 47: 2 added (0.54% of the fund), 0 dropped (0%). Turnover proxy 4.4%. Largest increases: Merck & Co Inc 4.33% to 5.64%; Johnson & Johnson 22.7% to 23.11%; Pfizer Inc 17.17% to 17.54%; Pacira BioSciences Inc 0.94% to 1.15%; Prestige Consumer Healthcare Inc 0.63% to 0.82%; Bristol-Myers Squibb Co 4.5% to 4.64%. Largest decreases: Amicus Therapeutics Inc 2.18% to 0.97%; Elanco Animal Health Inc 4.69% to 4.03%; Eli Lilly and Co 4.72% to 4.07%; Catalent Inc 4.98% to 4.57%; Viatris Inc 4.72% to 4.45%; Axsome Therapeutics Inc 0.78% to 0.56%. New: Atea Pharmaceuticals Inc (0.29%), NGM Biopharmaceuticals Inc (0.25%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 27 May 2021 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/49 positions became 45: 1 added (4.72% of the fund), 5 dropped (6.47%). Turnover proxy 22.4%. Largest increases: Pfizer Inc 4.56% to 17.17%; Elanco Animal Health Inc 3.7% to 4.69%; Arvinas Inc 0.23% to 0.95%; Amicus Therapeutics Inc 1.48% to 2.18%; Catalent Inc 4.54% to 4.98%; Johnson & Johnson 22.35% to 22.7%. Largest decreases: Merck & Co Inc 19.09% to 4.33%; Perrigo Co PLC 2.54% to 2.21%; Horizon Therapeutics Plc 4.82% to 4.61%; Prestige Consumer Healthcare Inc 0.74% to 0.63%; Pacira BioSciences Inc 1.04% to 0.94%; Bristol-Myers Squibb Co 4.59% to 4.5%. New: Viatris Inc (4.72%). Gone: Mylan NV (3.1%), MyoKardia Inc (2.92%), Intersect ENT Inc (0.22%), AMAG Pharmaceuticals Inc (0.11%), Tricida Inc (0.11%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 25 Feb 2021 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/45 positions became 49: 4 added (3.01% of the fund), 0 dropped (0%). Turnover proxy 6.1%. Largest increases: Johnson & Johnson 21.73% to 22.35%; MyoKardia Inc 2.34% to 2.92%; Merck & Co Inc 18.59% to 19.09%; Jazz Pharmaceuticals PLC 2.8% to 3.2%; Pfizer Inc 4.16% to 4.56%; Zoetis Inc 4.47% to 4.68%. Largest decreases: Reata Pharmaceuticals Inc 1.89% to 0.95%; Perrigo Co PLC 3.46% to 2.54%; Mylan NV 3.81% to 3.1%; Eli Lilly and Co 4.96% to 4.38%; Amicus Therapeutics Inc 1.78% to 1.48%; Axsome Therapeutics Inc 1.02% to 0.76%. New: Royalty Pharma PLC (1.37%), ChemoCentryx Inc (1.1%), Collegium Pharmaceutical Inc (0.29%), Provention Bio Inc (0.25%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 25 Nov 2020 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/46 positions became 45: 2 added (0.48% of the fund), 3 dropped (4.46%). Turnover proxy 8%. Largest increases: Horizon Therapeutics Plc 3.1% to 4.86%; Johnson & Johnson 20.16% to 21.73%; MyoKardia Inc 1.21% to 2.34%; Eli Lilly and Co 4.02% to 4.96%; Amicus Therapeutics Inc 1.31% to 1.78%; Merck & Co Inc 18.26% to 18.59%. Largest decreases: Elanco Animal Health Inc 4.95% to 3.92%; Mylan NV 4.3% to 3.81%; Jazz Pharmaceuticals PLC 3.15% to 2.8%; Perrigo Co PLC 3.66% to 3.46%; Prestige Consumer Healthcare Inc 1.03% to 0.86%; Reata Pharmaceuticals Inc 2.06% to 1.89%. New: Relmada Therapeutics Inc (0.28%), Phathom Pharmaceuticals Inc (0.2%). Gone: Allergan PLC (4.34%), WaVe Life Sciences Ltd (0.09%), Akorn Inc (0.03%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 27 Aug 2020 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/47 positions became 46: 0 added (0% of the fund), 1 dropped (0.28%). Turnover proxy 5.5%. Largest increases: Catalent Inc 3.24% to 4.49%; Perrigo Co PLC 2.76% to 3.66%; Elanco Animal Health Inc 4.32% to 4.95%; Horizon Therapeutics Plc 2.67% to 3.1%; Amicus Therapeutics Inc 0.98% to 1.31%; Prestige Consumer Healthcare Inc 0.8% to 1.03%. Largest decreases: Johnson & Johnson 22.25% to 20.16%; Merck & Co Inc 19.22% to 18.26%; Eli Lilly & Co 4.68% to 4.02%; Pfizer Inc 4.41% to 4.19%; Axsome Therapeutics Inc 1.08% to 0.88%; Jazz Pharmaceuticals PLC 3.32% to 3.15%. Gone: Dermira Inc (0.28%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 01 Jun 2020 12:00:00 GMThttps://themulden.com/funds/ihe/https://themulden.com/funds/ihe/47 positions became 47: 1 added (0.25% of the fund), 1 dropped (0.14%). Turnover proxy 5.4%. Largest increases: Reata Pharmaceuticals Inc 0.81% to 2.05%; Axsome Therapeutics Inc 0.22% to 1.08%; Intra-Cellular Therapies Inc 0.15% to 0.62%; Horizon Therapeutics Plc 2.22% to 2.67%; MyoKardia Inc 1.05% to 1.33%; Ironwood Pharmaceuticals Inc 0.59% to 0.82%. Largest decreases: Merck & Co Inc 21.68% to 19.22%; Perrigo Co PLC 3.32% to 2.76%; Johnson & Johnson 22.69% to 22.25%; Bristol-Myers Squibb Co 4.74% to 4.42%; Allergan PLC 4.67% to 4.4%; Spectrum Pharmaceuticals Inc 0.41% to 0.16%. New: Arvinas Holding Co LLC (0.25%). Gone: Cymabay Therapeutics Inc (0.14%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 27 Feb 2020 12:00:00 GMT